- Home
- CTLP vs AUTL Comparison
CTLP vs AUTL Comparison
Compare CTLP & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTLP
- AUTL
- Stock Information
- Founded
- CTLP 1992
- AUTL 2014
- Country
- CTLP United States
- AUTL United Kingdom
- Employees
- CTLP N/A
- AUTL N/A
- Industry
- CTLP EDP Services
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CTLP Technology
- AUTL Health Care
- Exchange
- CTLP Nasdaq
- AUTL Nasdaq
- Market Cap
- CTLP 642.2M
- AUTL 625.4M
- IPO Year
- CTLP N/A
- AUTL 2018
- Fundamental
- Price
- CTLP $11.07
- AUTL $2.41
- Analyst Decision
- CTLP Hold
- AUTL Strong Buy
- Analyst Count
- CTLP 5
- AUTL 5
- Target Price
- CTLP $11.50
- AUTL $9.32
- AVG Volume (30 Days)
- CTLP 3.1M
- AUTL 2.1M
- Earning Date
- CTLP 05-08-2025
- AUTL 08-07-2025
- Dividend Yield
- CTLP N/A
- AUTL N/A
- EPS Growth
- CTLP 404.65
- AUTL N/A
- EPS
- CTLP 0.80
- AUTL N/A
- Revenue
- CTLP $292,642,000.00
- AUTL $9,011,000.00
- Revenue This Year
- CTLP $15.56
- AUTL $461.76
- Revenue Next Year
- CTLP $14.42
- AUTL $112.66
- P/E Ratio
- CTLP $13.84
- AUTL N/A
- Revenue Growth
- CTLP 12.51
- AUTL N/A
- 52 Week Low
- CTLP $5.82
- AUTL $1.11
- 52 Week High
- CTLP $11.36
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- CTLP 74.77
- AUTL 70.63
- Support Level
- CTLP $10.96
- AUTL $2.20
- Resistance Level
- CTLP $11.10
- AUTL $2.44
- Average True Range (ATR)
- CTLP 0.07
- AUTL 0.12
- MACD
- CTLP -0.03
- AUTL -0.01
- Stochastic Oscillator
- CTLP 96.96
- AUTL 84.95
About CTLP Cantaloupe Inc.
Cantaloupe Inc operates in the small ticket electronic payments industry. It provides wireless, cashless, micro-transactions, and networking services within the unattended Point of Sale (POS) market. Its products and services portfolio consists of ePort Cashless devices, eSuds, EnergyMisers, and Value-added services which include Loyalty and Prepaid, Intelligent Vending, and others. The company offers services to different industries covering car wash, taxi and transportation, laundry, vending, kiosk, amusement, and arcade. The company derives revenue from the sale or lease of equipment and services to the small ticket, unattended POS market, and the majority of its revenue is derived from subscription and transaction fees.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.